Title | Type | SJR | H index | Total Docs. (2010) | Total Docs. (3years) | Total Refs. (2010) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2010) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
165 | Life Science Clusters | trade journal | 0.100 Q4 | 0 | 11 | 60 | 0 | 0 | 55 | 0.00 | 0.00 | |
164 | Next Generation Pharmaceutical | trade journal | 0.100 Q4 | 1 | 81 | 109 | 0 | 1 | 75 | 0.01 | 0.00 | |
163 | Pharmaceutical Manufacturing and Packing Sourcer | trade journal | 0.100 Q4 | 3 | 67 | 71 | 246 | 1 | 71 | 0.01 | 3.67 | |
162 | Pharmacy News | journal | 0.100 Q4 | 1 | 121 | 749 | 0 | 1 | 286 | 0.00 | 0.00 | |
161 | Sp2 | trade journal | 0.100 Q4 | 2 | 74 | 64 | 64 | 1 | 58 | 0.02 | 0.86 | |
160 | Drugs in Context | journal | 0.101 Q4 | 36 | 0 | 31 | 0 | 0 | 26 | 0.00 | 0.00 | |
159 | EPC - European Pharmaceutical Contractor | journal | 0.101 Q4 | 3 | 60 | 275 | 206 | 2 | 267 | 0.01 | 3.43 | |
158 | Journal of Clinical Research | journal | 0.103 Q4 | 12 | 0 | 6 | 0 | 0 | 6 | 0.00 | 0.00 | |
157 | Manufacturing Chemist | trade journal | 0.103 Q4 | 6 | 109 | 247 | 156 | 2 | 226 | 0.01 | 1.43 | |
156 | ONdrugDelivery | trade journal | 0.105 Q4 | 7 | 36 | 4 | 264 | 0 | 4 | 0.00 | 7.33 | |
155 | Signal | journal | 0.105 Q4 | 1 | 0 | 5 | 0 | 0 | 4 | 0.00 | 0.00 | |
154 | Pharmacy in Practice | journal | 0.108 Q4 | 6 | 0 | 147 | 0 | 3 | 127 | 0.01 | 0.00 | |
153 | Quality Assurance Journal | journal | 0.109 Q4 | 11 | 11 | 47 | 73 | 11 | 39 | 0.10 | 6.64 | |
152 | EBR - European Biopharmaceutical Review | journal | 0.111 Q4 | 6 | 51 | 234 | 342 | 3 | 233 | 0.02 | 6.71 | |
151 | Alimentary Pharmacology and Therapeutics Symposium Series | journal | 0.118 Q3 | 8 | 0 | 12 | 0 | 1 | 12 | 0.00 | 0.00 | |
150 | European Pharmaceutical Review | trade journal | 0.120 Q3 | 9 | 43 | 29 | 799 | 4 | 23 | 0.14 | 18.58 | |
149 | Journal of Applied Therapeutic Research | journal | 0.124 Q4 | 8 | 8 | 26 | 169 | 5 | 26 | 0.14 | 21.13 | |
148 | International Journal of Neuroprotection and Neuroregeneration | journal | 0.136 Q4 | 5 | 0 | 29 | 0 | 5 | 24 | 0.27 | 0.00 | |
147 | Journal of Generic Medicines (discontinued) | journal | 0.136 Q3 | 16 | 45 | 118 | 839 | 26 | 108 | 0.23 | 18.64 | |
146 | Pharmaceutical Medicine | journal | 0.136 Q4 | 25 | 36 | 135 | 764 | 42 | 106 | 0.29 | 21.22 | |
145 | Innovations in Pharmaceutical Technology | trade journal | 0.138 Q3 | 9 | 64 | 197 | 271 | 17 | 189 | 0.11 | 4.23 | |
144 | Paediatric and Perinatal Drug Therapy | journal | 0.159 Q4 | 20 | 0 | 30 | 0 | 17 | 26 | 0.33 | 0.00 | |
143 | Drug Discovery World | journal | 0.164 Q4 | 14 | 59 | 125 | 457 | 45 | 113 | 0.43 | 7.75 | |
142 | International Journal of Computational Biology and Drug Design | journal | 0.176 Q4 | 16 | 25 | 55 | 748 | 24 | 55 | 0.44 | 29.92 | |
141 | Issues in Toxicology | book series | 0.190 Q3 | 18 | 36 | 69 | 2414 | 32 | 64 | 0.65 | 67.06 | |
140 | Drug Discovery Today: Technologies | journal | 0.193 Q4 | 62 | 35 | 50 | 1374 | 35 | 43 | 0.69 | 39.26 | |
139 | Pharmaceutical Journal | journal | 0.211 Q3 | 28 | 849 | 3171 | 639 | 113 | 864 | 0.03 | 0.75 | |
138 | Journal of Venomous Animals and Toxins Including Tropical Diseases | journal | 0.213 Q4 | 41 | 77 | 178 | 2021 | 76 | 163 | 0.36 | 26.25 | |
137 | Personalized Medicine | journal | 0.215 Q3 | 36 | 92 | 200 | 2879 | 136 | 161 | 0.69 | 31.29 | |
136 | Expert Review of Clinical Pharmacology | journal | 0.218 Q2 | 60 | 68 | 129 | 5932 | 95 | 110 | 0.74 | 87.24 | |
135 | IDrugs : the investigational drugs journal | journal | 0.235 Q3 | 39 | 176 | 501 | 2025 | 259 | 501 | 0.59 | 11.51 | |
134 | Future HIV Therapy | journal | 0.236 Q3 | 8 | 0 | 57 | 0 | 35 | 46 | 0.61 | 0.00 | |
133 | Chemical Speciation and Bioavailability | journal | 0.242 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
132 | Toxin Reviews | journal | 0.258 Q3 | 54 | 11 | 67 | 966 | 69 | 64 | 1.08 | 87.82 | |
131 | HIV Therapy | journal | 0.260 Q3 | 14 | 48 | 60 | 4159 | 25 | 42 | 0.42 | 86.65 | |
130 | Toxicology Mechanisms and Methods | journal | 0.278 Q3 | 55 | 74 | 230 | 3336 | 243 | 224 | 1.10 | 45.08 | |
129 | Food Additives and Contaminants: Part B Surveillance | journal | 0.292 Q3 | 41 | 39 | 47 | 1187 | 49 | 46 | 1.04 | 30.44 | |
128 | DARU, Journal of Pharmaceutical Sciences | journal | 0.293 Q3 | 58 | 48 | 150 | 1092 | 131 | 149 | 0.93 | 22.75 | |
127 | Bioanalysis | journal | 0.298 Q2 | 70 | 176 | 128 | 6229 | 140 | 113 | 1.09 | 35.39 | |
126 | Pharmaceutical Biology | journal | 0.315 Q2 | 88 | 227 | 440 | 6719 | 374 | 434 | 0.78 | 29.60 | |
125 | Drug Discovery Today: Disease Mechanisms | journal | 0.317 Q3 | 28 | 31 | 89 | 1578 | 79 | 78 | 0.87 | 50.90 | |
124 | Drug Discovery Today: Therapeutic Strategies | journal | 0.319 Q3 | 31 | 12 | 101 | 524 | 71 | 86 | 0.71 | 43.67 | |
123 | Advances in Antiviral Drug Design | book series | 0.320 Q2 | 12 | 0 | 7 | 0 | 6 | 6 | 0.00 | 0.00 | |
122 | Biomarkers in Medicine | journal | 0.326 Q3 | 56 | 95 | 120 | 5641 | 122 | 92 | 1.02 | 59.38 | |
121 | Drug Discovery Today: Disease Models | journal | 0.330 Q3 | 33 | 19 | 96 | 746 | 62 | 82 | 0.65 | 39.26 | |
120 | Therapeutic Advances in Neurological Disorders | journal | 0.339 Q3 | 68 | 33 | 51 | 2177 | 45 | 44 | 0.88 | 65.97 | |
119 | International Journal of Pharmacy Practice | journal | 0.340 Q2 | 44 | 120 | 224 | 1659 | 108 | 204 | 0.39 | 13.83 | |
118 | Cutaneous and Ocular Toxicology | journal | 0.343 Q3 | 37 | 51 | 99 | 1201 | 126 | 98 | 1.03 | 23.55 | |
117 | Journal of Asian Natural Products Research | journal | 0.350 Q2 | 51 | 159 | 488 | 2639 | 419 | 488 | 0.79 | 16.60 | |
116 | Drug Testing and Analysis | journal | 0.352 Q2 | 67 | 81 | 81 | 2301 | 113 | 73 | 1.40 | 28.41 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®